MARC details
000 -LEADER |
fixed length control field |
04374nam a22007217a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
140821s20132013 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1553-5592 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
24022878 |
245 ## - TITLE STATEMENT |
Title |
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. |
251 ## - Source |
Source |
Journal of Hospital Medicine (Online). 8(10):559-63, 2013 Oct. |
252 ## - Abbreviated Source |
Abbreviated source |
J Hosp Med. 8(10):559-63, 2013 Oct. |
253 ## - Journal Name |
Journal name |
Journal of hospital medicine : an official publication of the Society of Hospital Medicine |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2013 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2014 |
266 ## - Date added to catalog |
Date added to catalog |
2014-08-21 |
501 ## - WITH NOTE |
Local holdings |
Available in print through MWHC library: 2007 only |
520 ## - SUMMARY, ETC. |
Abstract |
BACKGROUND: Antimicrobial resistance complicates antibiotic selection. Pseudomonas aeruginosa (PA), common in pneumonia and blood stream infections (BSIs), is frequently resistant to multiple antimicrobial classes. Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a pathogen of concern over the past decade. |
520 ## - SUMMARY, ETC. |
Abstract |
CONCLUSIONS: Although CRE organisms have emerged as an important pathogen in BSI and pneumonia, MDR-PA remains more prevalent in the United States. 2013 Society of Hospital Medicine. |
520 ## - SUMMARY, ETC. |
Abstract |
DESIGN: Survey of data from a nationally representative sample of microbiology laboratories in 217 hospitals in the United States. |
520 ## - SUMMARY, ETC. |
Abstract |
METHODS/SETTING: We examined Eurofins' The Surveillance Network database from 2000 to 2009 to explore the proportion of all PA in pneumonia and BSI that is MDR. We performed the same analysis for CRE as a proportion of Enterobacteriaceae. We defined MDR-PA as any isolate resistant to >3 drug classes. Enterobacteriaceae were CRE if resistant to both a third generation cephalosporin and a carbapenem. |
520 ## - SUMMARY, ETC. |
Abstract |
OBJECTIVE: To determine the prevalence of CRE and multidrug-resistant PA (MDR-PA) in pneumonia and BSI hospitalizations. |
520 ## - SUMMARY, ETC. |
Abstract |
RESULTS: We identified 205,526 PA (187,343 pneumonia; 18,183 BSI) and 95,566 Enterobacteriaceae specimens (58,810 pneumonia; 36,756 BSI). The prevalence of MDR-PA was ~15-fold higher than CRE in both infection types (pneumonia: 22.0% MDR-PA vs 1.6% CRE; BSI: 14.7% MDR-PA vs 1.1% CRE). There was a net rise in MDR-PA as a proportion of all PA from 2000 to 2009 (BSI: 10.7%-13.5%; pneumonia: 19.2%-21.7%). The CRE phenotype emerged in 2002 in both infection types, peaking in 2008 at 3.6% in BSI and 5.3% in pneumonia, and stabilized thereafter. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Carbapenems/tu [Therapeutic Use] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Cross Infection/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Drug Resistance, Multiple, Bacterial/de [Drug Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Enterobacteriaceae/de [Drug Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Pneumonia, Bacterial/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Pseudomonas aeruginosa/de [Drug Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Adult |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Aged |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Carbapenems/pd [Pharmacology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cross Infection/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Databases, Factual |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Resistance, Multiple, Bacterial/ph [Physiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Enterobacteriaceae Infections/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Enterobacteriaceae Infections/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Enterobacteriaceae/ip [Isolation & Purification] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Female |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Hospitalization/td [Trends] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Humans |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Male |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Middle Aged |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pneumonia, Bacterial/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Prevalence |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pseudomonas aeruginosa/ip [Isolation & Purification] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pseudomonas Infections/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pseudomonas Infections/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Sepsis/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Sepsis/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
United States/ep [Epidemiology] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Young Adult |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Washington Hospital Center |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine/Pulmonary-Critical Care |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Multicenter Study |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Research Support, Non-U.S. Gov't |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Shorr, Andrew F |
790 ## - Authors |
All authors |
Shorr AF, Zilberberg MD |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="http://dx.doi.org/10.1002/jhm.2080">http://dx.doi.org/10.1002/jhm.2080</a> |
Public note |
http://dx.doi.org/10.1002/jhm.2080 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |